Soluble guanylate cyclase activators for treating portal hypertension

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12226411
APP PUB NO 20230293513A1
SERIAL NO

18123359

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to methods for treating patients with compensated cirrhosis, comprising administering to a patient in need thereof a therapeutically effective amount of a soluble guanylate cyclase (sGC) activator, or a pharmaceutically acceptable salt thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ertle, Judith Maria Ingelheim am Rhein, DE 1 0
Huber, Jochen Mittelbiberach, DE 26 380
Seman, Leo John Cheshire, US 14 249

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Aug 18, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 18, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 18, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00